NEW YORK (GenomeWeb News) – Scienion and Innopsys today announced an agreement to combine each other's microarray technologies in a single offering to customers.

The firms said they will integrate their technologies for a broad range of applications and highlighted the integration of Scienion's sciFlexArrayer technology, which can be used for reverse-phase protein arrays, with Innopsys' InnoScan 710-IR near-infrared scanner, resulting in a product that "will significantly improve signal-to-noise ratios."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.